As shown in Figure 6, AC-MFB treatment suppressed the DFO-stimulated VEGF secretion in both HCC cell lines, but only the difference in HA22T/VGH cells reached statistical significance (P < 0.05). Here, VEGFA is linked to hepatocellular carcinoma.